Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom

Lucy T Perry; Alice Bhasale; Alice Fabbri; Joel Lexchin; Lorri Puil; Maisah Joarder; Barbara Mintzes

doi:10.1001/jamainternmed.2019.0294

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom

JAMA Intern Med. 2019 Jul 1;179(7):982-984. doi: 10.1001/jamainternmed.2019.0294.

Authors

Lucy T Perry¹, Alice Bhasale¹, Alice Fabbri¹, Joel Lexchin², Lorri Puil³, Maisah Joarder¹, Barbara Mintzes¹

Affiliations

¹ Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
² School of Health Policy and Management, Faculty of Health, York University, Toronto, Ontario, Canada.
³ Department of Anaesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Abstract

This study examines how often medicines regulators in Australia, Canada, the United Kingdom, and the United States were concordant in their decisions to issue safety advisories on approved prescription medicines.

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Australia
Canada
Drug and Narcotic Control / statistics & numerical data*
United Kingdom
United States

Grants and funding

PJT-153275/CIHR/Canada